LAS-PACC5

1. LAS-PACC5 is associated with Multilingual Naming Test in humans (r = 0.34, p < .001).

   “and the MINT ( r = 0.34, p < .001).”

   HumansSpanish-speaking participantsn = 191

   The Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino Populations

   AAIC 2025 abstract·25 Dec 2025

More on Multilingual Naming Test

1. LAS-PACC5 is associated with semantic fluency in humans (rs = 0.46, p < .001).

   “semantic fluency (fruits) (rs=0.46, p < .001)”

   HumansSpanish-speaking participantsn = 191

   The Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino Populations

   AAIC 2025 abstract·25 Dec 2025

More on Semantic fluency

1. LAS-PACC5 is associated with NEUROPSI Word List in humans (rs = 0.32, p < .001).

   “The LAS‐PACC5 showed positive correlations with the NEUROPSI Word List (rs = 0.32, p < .001)”

   HumansSpanish-speaking participantsn = 191

   The Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino Populations

   AAIC 2025 abstract·25 Dec 2025

More on NEUROPSI Word List

1. LAS-PACC5 is associated with cognitive impairment in humans (r = -0.66, p < .001).

   “Additionally, LAS‐PACC5 distinguished between unimpaired participants (M = ‐0.19 ± 3.34) and impaired participants (M = ‐13.38 ± 11.40) with a significant difference in the distribution of summary scores ( p < .001) and a large effect size ( r = ‐0.66).”

   HumansSpanish-speaking participantsn = 191

   The Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino Populations

   AAIC 2025 abstract·25 Dec 2025

More on Cognitive impairment